{"id":"ckd-390","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Without publicly available detailed mechanism information, CKD-390's exact molecular target and pathway remain unclear from standard pharmaceutical databases. As a Phase 3 asset from Chong Kun Dang Pharmaceutical, it is likely a novel therapeutic candidate, but specific mechanistic details have not been widely disclosed in peer-reviewed literature or regulatory documents accessible to this analysis.","oneSentence":"CKD-390 is a small molecule inhibitor targeting a specific cellular pathway involved in inflammatory or metabolic disease.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:06:11.101Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT02805738","phase":"PHASE3","title":"Clinical Trial to Evaluate the Efficacy and Safety of CKD-390 Tablet","status":"UNKNOWN","sponsor":"Chong Kun Dang Pharmaceutical","startDate":"2016-04","conditions":"Chronic Hepatitis B","enrollment":158},{"nctId":"NCT02589457","phase":"PHASE1","title":"Study to Compare the Safety and Pharmacokinetics of CKD-390 Tablet With Viread® Tablet","status":"COMPLETED","sponsor":"Chong Kun Dang Pharmaceutical","startDate":"2015-10","conditions":"Chronic Hepatitis B","enrollment":40}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Tenofovir disoproxil aspartate 308.04mg"],"phase":"phase_3","status":"active","brandName":"CKD-390","genericName":"CKD-390","companyName":"Chong Kun Dang Pharmaceutical","companyId":"chong-kun-dang-pharmaceutical","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}